Detection of disseminated tumor cells from the bone marrow of patients with early breast cancer is associated with high 21-gene recurrence score

被引：0
|
作者：
Hartkopf, A. [1 ]
Wallwiener, M. [2 ]
Kammoss, S. [1 ]
Brucker, S. [1 ]
Taran, F-A [1 ]
机构：
[1] Univ Tubingen, Tubingen, Germany
[2] Heidelberg Univ, Gynecol & Obstet, Bergheimer Str 58, D-69115 Heidelberg, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2016年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
0586
引用
收藏
页码：165 / 165
页数：1
相关论文
共 50 条
  • [41] The 21-gene recurrence score in early non-ductal breast cancer: A national cancer database analysis
    Makower, Della
    Qin, Jiyue
    Lin, Juan
    Xue, Xiaonan
    Sparano, Joseph A.
    CANCER RESEARCH, 2021, 81 (04)
  • [42] COST-BENEFIT ANALYSIS OF A 21-GENE RECURRENCE SCORE FOR EARLY STAGE BREAST CANCER IN SINGAPORE
    de Lima, Lopes G.
    Chien, R.
    Hornberger, J.
    VALUE IN HEALTH, 2010, 13 (07) : A512 - A512
  • [43] Influence of a 21-Gene Recurrence Score Assay on Chemotherapy Delivery in Breast Cancer
    Rutter, Charles E.
    Yao, Xiaopan
    Mancini, Brandon R.
    Aminawung, Jenerius A.
    Chagpar, Anees B.
    Saglam, Ozlen
    Hofstatter, Erin W.
    Abu-Khalaf, Maysa
    Gross, Cary P.
    Evans, Suzanne B.
    CLINICAL BREAST CANCER, 2016, 16 (01) : 59 - 62
  • [44] Effect of 21-gene recurrence score in decision-making for surgery in early stage breast cancer
    Wu, San-Gang
    Zhang, Wen-Wen
    Wang, Jun
    Dong, Yong
    Chen, Yong-Xiong
    He, Zhen-Yu
    ONCOTARGETS AND THERAPY, 2019, 12 : 2071 - 2078
  • [45] Evaluation Oncotype DX® 21-Gene Recurrence Score and clinicopathological parameters in early stage breast cancer
    Lashen, A. L.
    Toss, M. T.
    Fadhil, W. F.
    Oni, G. O.
    Madhusudan, S. M.
    Rakha, E. R.
    JOURNAL OF PATHOLOGY, 2023, 261 : S10 - S10
  • [46] Cost-benefit analysis of a 21-gene recurrence score for early stage breast cancer in Singapore
    Lopes, G. de Lima
    Chien, R.
    Hornberger, J. C.
    BREAST, 2011, 20 : S48 - S48
  • [47] Economic impact of 21-gene recurrence score testing on early-stage breast cancer in Ireland
    Lillian Smyth
    Geoff Watson
    Elaine M. Walsh
    Catherine M. Kelly
    Maccon Keane
    M. John Kennedy
    Liam Grogan
    Bryan T. Hennessy
    Seamus O’Reilly
    Linda E. Coate
    Miriam O’Connor
    Cecily Quinn
    Katharina Verleger
    Olaf Schoeman
    Susan O’Reilly
    Janice M. Walshe
    Breast Cancer Research and Treatment, 2015, 153 : 573 - 582
  • [48] The 21-gene recurrence score in early non-ductal breast cancer: a National Cancer Database analysis
    Della Makower
    Jiyue Qin
    Juan Lin
    Xiaonan Xue
    Joseph A. Sparano
    npj Breast Cancer, 8
  • [49] Metabolic syndrome and breast cancer recurrence within the 21-gene recurrence score assay.
    Muniz, Jeanette
    Kidwell, Kelley M.
    Henry, Norah Lynn
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (28)
  • [50] Associations between metabolic syndrome, breast cancer recurrence, and the 21-gene recurrence score assay
    Muniz, Jeanette
    Kidwell, Kelley M.
    Henry, N. Lynn
    BREAST CANCER RESEARCH AND TREATMENT, 2016, 157 (03) : 597 - 603
12345